Status:
COMPLETED
Assessing the Additional Neoplasia Yield of Computer-aided Colonoscopy in Follow-up Patients in a Screening Setting
Lead Sponsor:
Fondazione Poliambulanza Istituto Ospedaliero
Conditions:
Colonic Adenoma
Adenoma
Eligibility:
All Genders
50-74 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to evaluate the diagnostic yield of CADe in a consecutive population undergoing colonoscopy. The main question it aims to answer is the Adenoma Detection Rate (ADR)....
Detailed Description
en if colonoscopy is considered the reference standard for the detection of colonic neoplasia, polyps are still missed. In large administrative cohort or case-control studies, the risk of early post-c...
Eligibility Criteria
Inclusion
- Patients aged 50 to 74 undergoing colonoscopy examination following a prior colonsocopy were polyps were found (follow-up) performed in the context of a regional mass-screening program.
Exclusion
- Patients unwilling or unable to give informed consent.
- Patients reporting use of anti-platelet agents or anticoagulants precluding removal of polyps.
Key Trial Info
Start Date :
December 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2024
Estimated Enrollment :
1160 Patients enrolled
Trial Details
Trial ID
NCT06160466
Start Date
December 16 2020
End Date
May 1 2024
Last Update
August 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Poliambulanza
Brescia, Bs, Italy, 25124